Search Results for: FVIII

BIVV001

BIVV001, also known as rFVIIIFc-VWF-XTEN, is a novel investigational factor VIII (FVIII) therapy, developed by Bioverativ. It is designed to extend protection from bleeds in patients with hemophilia type A with prophylaxis ... Read more